Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China · Delayed Price · Currency is CNY 7.02
+0.14 (2.03%)
Apr 30, 2026, 1:25 PM CST
Shanghai Kinetic Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 852.25 | 946.1 | 962.74 | 933.63 | 1,146 | 1,258 |
Other Revenue | 16.97 | 16.97 | 21.78 | 22.63 | 19.77 | 10.44 |
| 869.21 | 963.06 | 984.52 | 956.26 | 1,166 | 1,269 | |
Revenue Growth (YoY) | -13.35% | -2.18% | 2.96% | -17.99% | -8.08% | 19.50% |
Cost of Revenue | 417.99 | 487.17 | 505.43 | 466.09 | 425.97 | 490.52 |
Gross Profit | 451.22 | 475.9 | 479.09 | 490.17 | 740.07 | 778.06 |
Selling, General & Admin | 335.17 | 352.18 | 348.72 | 353.05 | 436.31 | 406.76 |
Research & Development | 50.75 | 51.41 | 43.3 | 59.34 | 61.4 | 69.77 |
Other Operating Expenses | 5.29 | 6.75 | 5.56 | 6.97 | 10.44 | 9.67 |
Operating Expenses | 396.84 | 415.96 | 399.97 | 410.4 | 527.81 | 497.7 |
Operating Income | 54.39 | 59.93 | 79.12 | 79.78 | 212.26 | 280.36 |
Interest Expense | -7.47 | -7.47 | -6.67 | -6.56 | -14.12 | -22.66 |
Interest & Investment Income | 72.73 | 31.15 | 8.17 | 46.47 | 16.56 | 27.8 |
Currency Exchange Gain (Loss) | -1.66 | -1.66 | -0.53 | 0.48 | -2.33 | 1.12 |
Other Non Operating Income (Expenses) | 3.53 | -3.27 | -3.37 | -4.26 | -4.17 | -2.76 |
EBT Excluding Unusual Items | 121.51 | 78.68 | 76.73 | 115.9 | 208.2 | 283.86 |
Impairment of Goodwill | - | - | - | - | -197.99 | -149.26 |
Gain (Loss) on Sale of Investments | 54.99 | 56.75 | -195.07 | 1.19 | -28.9 | 35.25 |
Gain (Loss) on Sale of Assets | 0.29 | 0.26 | -0.1 | -0.37 | 0.21 | 1.6 |
Asset Writedown | -0.38 | -0.38 | -2.91 | -0.58 | -2.01 | -0.14 |
Other Unusual Items | 10.17 | 10.17 | 10.99 | 17.44 | 18.23 | 44.93 |
Pretax Income | 186.59 | 145.48 | -110.37 | 133.57 | -2.26 | 216.31 |
Income Tax Expense | 16.5 | 13.86 | -14.15 | 6.98 | 21.69 | 41.31 |
Earnings From Continuing Operations | 170.09 | 131.62 | -96.22 | 126.6 | -23.95 | 175 |
Minority Interest in Earnings | 9.12 | 3.27 | -9.35 | -14.06 | 2.67 | -13.22 |
Net Income | 179.22 | 134.89 | -105.57 | 112.54 | -21.28 | 161.78 |
Net Income to Common | 179.22 | 134.89 | -105.57 | 112.54 | -21.28 | 161.78 |
Shares Outstanding (Basic) | 717 | 717 | 717 | 717 | 719 | 722 |
Shares Outstanding (Diluted) | 717 | 717 | 717 | 717 | 719 | 722 |
Shares Change (YoY) | -0.14% | -0.01% | 0.05% | -0.31% | -0.40% | -0.16% |
EPS (Basic) | 0.25 | 0.19 | -0.15 | 0.16 | -0.03 | 0.22 |
EPS (Diluted) | 0.25 | 0.19 | -0.15 | 0.16 | -0.03 | 0.22 |
Free Cash Flow | 153.3 | 122.88 | 74.91 | 220.47 | 195.3 | 328.94 |
Free Cash Flow Per Share | 0.21 | 0.17 | 0.10 | 0.31 | 0.27 | 0.46 |
Dividend Per Share | 0.100 | 0.100 | - | 0.060 | - | 0.050 |
Gross Margin | 51.91% | 49.41% | 48.66% | 51.26% | 63.47% | 61.33% |
Operating Margin | 6.26% | 6.22% | 8.04% | 8.34% | 18.20% | 22.10% |
Profit Margin | 20.62% | 14.01% | -10.72% | 11.77% | -1.82% | 12.75% |
Free Cash Flow Margin | 17.64% | 12.76% | 7.61% | 23.06% | 16.75% | 25.93% |
EBITDA | 98.73 | 109.31 | 148.63 | 145.6 | 273.16 | 337.18 |
EBITDA Margin | 11.36% | 11.35% | 15.10% | 15.23% | 23.43% | 26.58% |
D&A For EBITDA | 44.35 | 49.38 | 69.52 | 65.83 | 60.9 | 56.81 |
EBIT | 54.39 | 59.93 | 79.12 | 79.78 | 212.26 | 280.36 |
EBIT Margin | 6.26% | 6.22% | 8.04% | 8.34% | 18.20% | 22.10% |
Effective Tax Rate | 8.84% | 9.53% | - | 5.22% | - | 19.10% |
Revenue as Reported | 963.06 | 963.06 | 984.52 | 956.26 | 1,166 | 1,269 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.